CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
eClinical Solutions Market To Double In 5 Years, As Sponsors Prioritize Efficiency
The global eClinical solutions market is projected to reach $22.1 million in 2029, double its presence in 2024. Experts discuss the specific solutions driving market growth and share how they impact clinical operations.
-
Is Double Programming Really Required For Validation?
Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.
ECOA RESOURCES
-
Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.
-
Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.
-
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
ECONSENT RESOURCES
-
Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.
-
Watch this webinar to see the latest eConsent workflow from recruitment, to pre-screening, to remote consent.
-
As much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process.
EPRO RESOURCES
-
In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies, particularly in light of FDA expectations.
-
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
Discover effective strategies and solutions to overcome challenges in oncology studies and how to optimize trial design, patient recruitment, data management, and regulatory compliance.